YL-205

N/A

Report date: 2026/01/12 15:14:01

Base Information

Drug NameYL-205
Drug Alias NameYL205YL-205
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDNA topoisomerase I inhibitorsSodium-dependent phosphate transport protein 2B inhibitors
TargetsDNA topoisomerase ISodium-dependent phosphate transport protein 2B
Therapy Area/IndicationsSolid tumoursOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMediLink Therapeutics Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesMediLink Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A